Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SALIX PHARMACEUTICALS INC Key Ratios

  • Valuation Ratio: SLXP

    P/E (TTM) -9.01
    Price to CashFlow -44.40
    Price to Sales (TTM) 2.37
    Price to Book 4.40
  • Per Share Ratio: SLXP

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 4.46
    EPS Fully Diluted -0.98
    Revenue Per Share 3.73
  • 5 Year Annual Growth: SLXP

    Net Income
    Revenue 26.22%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: SLXP

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: SLXP

    Operations Margin -26.10%
    Net Profit Margin -26.31%
    Gross Profit Margin 69.96%
  • Financial Strength: SLXP

    Quick Ratio (MRQ) 2.22
    Current Ratio (MRQ) 1.98
    LT Debt to Equity (MRQ) 26.23
    Total Debt to Equity (MRQ) 26.58
    Return on Equity (ROE) Per Share -17.22
    Return on Assets (ROA) -11.10
    Return on Invested Capital (ROIC) -14.63
  • Assets: SLXP

    Asset Turnover 0.45
    Inventory Turnover 2.33